HTA7 Cost-Effectiveness Analysis of Nivolumab Plus Chemotherapy Vs Chemotherapy in Patients with Advanced Gastric Cancer in Japan
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.1141
https://www.valueinhealthjournal.com/article/S1098-3015(22)01342-0/fulltext
Title :
HTA7 Cost-Effectiveness Analysis of Nivolumab Plus Chemotherapy Vs Chemotherapy in Patients with Advanced Gastric Cancer in Japan
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)01342-0&doi=10.1016/j.jval.2022.04.1141
First page :
Section Title :
Open access? :
No
Section Order :
11019